A descriptive, open-label, long-term follow-up survey of psychotic patients receiving risperidone long-acting injectable: Preliminary results

By Viala Annie   Cornic Francoise   Benamor Cyrine   Baldacci Chantal   Cheref Smail   Gauillard Jacques   Martin Pascal   Caroli Francois   Vacheron Marie Noëlle  

International Journal of Psychiatry in Clinical Practice, Vol. 13, Iss. 2, 2009-06 ,pp. : 138-146

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Effectiveness and tolerability of long-acting risperidone: A 9-month open-label extension of a 12-week switching study from oral antipsychotics

By Kim Chang Yoon   Chung Seockhoon   Hahm Bong-Jin   Hong Kyung Sue   Yoon Jin-Sang   Kim Young-Hoon   Bahk Won-Myong   Lee Sang-Yeol   Lee Yanghyun   Chung In-Won   Kim Chan-Hyung  

International Journal of Psychiatry in Clinical Practice, Vol. 13, Iss. 3, 2009-09 ,pp. : 192-198

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Risperidone long-acting injection, a promising treatment for patients with bipolar disorder

By Dratcu Luiz   Bamelis Dominiek   Libretto Susan  

Journal of Mental Health, Vol. 14, Iss. 5, 2005-10 ,pp. : 523-529

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of a Treatment Manual for Risperidone Long-Acting Injectable

By Docherty John   Jones Robert   Turkoz Ibrahim   Lasser Robert   Kujawa Mary  

Community Mental Health Journal, Vol. 43, Iss. 3, 2007-06 ,pp. : 267-280

Springer Publishing Company

Access to resources Recommend Favorite

Duration of Pharmacotherapy with Long-Acting Injectable Risperidone in the Treatment of Schizophrenia

By Mohamed Somaia   Rosenheck Robert   Harpaz-Rotem Ilan   Leslie Douglas   Sernyak Michael  

Psychiatric Quarterly, Vol. 80, Iss. 4, 2009-12 ,pp. : 241-249

Springer Publishing Company

Access to resources Recommend Favorite